“Award Winning Alerts”
Click above to visit: Wolf Of Penny Stocks
Donate To Hereitfirst!
Stock Market News Feed- Why it's time for investors to go on defense October 4, 2018
- Premarket: 7 things to know before the bell October 4, 2018
- Barnes & Noble stock soars 20% as it explores a sale October 3, 2018
- Toys 'R' Us brand may be brought back to life October 3, 2018
- Honda teams up with GM on self-driving cars October 3, 2018
Tag Archives: afrezza
Stock Picks/Earnings for 4-10, Recap of 4-9
Its that time of the year again! Earnings season! Notable earnings coming up. Google 4/16 Amazon 4/24 Under Armour 4/24 Apple 4/23 TSLA 5/14. I will most likely put Calls on Google and Amazon. Puts on TSLA ( Tesla) . … Continue reading
Posted in stock market
Tagged adcom, afrezza, amazon, amazon earnings, apple, apple earnings, diabeties, insulin, mnkd, PDUFA, PDUFA delay, rad earnings, rite aid, rite aid earnings, stock market, tesla, tesla earnings, tesla motors, tsla, under armor, under armor earnings, wallstreet
Leave a comment
Stock Picks for 4/8 Recap of Picks from 4/7
Stock Picks For Tomorrow 4-7 -HYSR, HYII, IPRU. HYSR is currently one of our LONG TERM PENNY STOCKS. However during the last few weeks HYSR was way too expensive IMO. Today’s drop put HYSR at an affordable price. HYSR still … Continue reading
Market Recap April Fools, Stock Picks for 3-2
Today was a great day but before we begin with our usual post I would like to get a point across to our fan base/ followers. Anyone who has made money from our advice and stock picks we do not … Continue reading
Posted in stock market
Tagged afrezza, diabetes, FDA approval, legalization, marijuana, marijuanastocks, mnkd, phot
Leave a comment
MannKind Corp. (MNKD) receives an “okay” from the FDA
After-hours today MannKind Corp. got a verbal “yes” from the FDA on their inhaled diabetes treatment, Afrezza. FDA approved advisors voted positively for the MNKD drug. Afrezza received a 13 to 1 vote for the drug to be used to … Continue reading
Posted in stock market, Uncategorized
Tagged afrezza, breakthrough, diabetes, fda, FDA staff, mankind, mannkind, MannKind Corp., medicine, mnkd, pharma, pharma stock, Pharmaceuticals, research, science, stock, stockmarket, Type 1 diabetes, Type 2 diabetes
1 Comment
BREAKING NEWS !!
GREAT NEWS ON AFREZZA !! MANNKIND WILL SOAR TOMORROW. Details to come Link to the original article on reuters click here.
Posted in stock market
Tagged afrezza, breaking news, FDA approval, kind, mannkind, mnkd
Leave a comment
Afrezza’s Outlook on April 1st
As you all may already know shares of MNKD were halted ahead of the AdCom. At Hereitfirst we have been monitoring for the last 4 months. We have come to believe that MNKD will almost certainly be approved for Type … Continue reading
Posted in stock market
Tagged adcom, afrezza, afrezza approval, diabetes, FDA approval, health care, inhalable insulin, mannkind, medicine, mnkd, type 2, type1
6 Comments
Market Recap for 3-31 Picks Stock Picks for 4-1
Breaking News Out of MYEC & PHOT ( 2 of our long Term Penny Stocks ) !! Financials are out ! For an analysis on MYEC click here ( MYEC is definitely going to Gap tomorrow) . Great news out of PHOT! … Continue reading
Posted in stock market
Tagged afrezza, FDA approval, investment, marijuana, mnkd, MYEC, pennystocks, phot, stock market, wallstreet
1 Comment
Stock Picks for 3-31 !!!
Big Week for our team at Hereitfirst. 3/4 of our analysts have a significant stake in MNKD! If Mannkind’s product Afrezza gets approved during Tuesday’s AdCom, This stock will soar. However if the FDA does not approve MNKD’s product this … Continue reading
Posted in stock market
Tagged adcom, afrezza, approval, artx, buyback, candy crush, daily picks, day trading, fda, holding, long term stocks, mannkind, marijuana, mnkd, pennystocks, PRPM
Leave a comment
Post Briefing Analysis On MNKD
MNKD had a roller coaster day as they stormed right out of the gate with highs of 5.75 ( Up 9% ) before closing at 4.83 ( down 7%). This could be attributed to the fact that good news came … Continue reading
Posted in stock market
Tagged afrezza, approval, briefing, diabetes, doctors, FDA approval, healthcare, insulin, mannkind, mannkind approval, medicine, mnkd
7 Comments
